Dengue virus non-structural protein (NS)

Dengue virus non-structural proteins are a group of seven viral proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) encoded by dengue virus, translated as part of a viral polyprotein and cleaved into functional components[2][3][4]. These proteins are essential for the viral replication cycle, including RNA replication (NS5 as RNA polymerase, NS3 as helicase/protease), polyprotein processing (NS3/NS2B), assembly of viral particles (NS1, NS2A, NS4A, NS4B), and antagonism of the host immune system (e.g., NS1 and NS5 interfere with interferon signaling)[1][2][3][4]. Multiple non-structural proteins (notably NS3, NS4B, and NS5) are established antiviral drug targets, though no approved drugs exist yet for direct inhibition[3][4]. NS1 is also secreted and widely used as a clinical biomarker for dengue infection[1][4]. The target "Dengue virus non-structural proteins" as a collective entry is overly broad and should refer to individual proteins where possible since their structures, functions, and suitability as drug targets differ markedly[3][4].

Other names

DENV NS proteinsDENV non-structural proteinsflavivirus non-structural proteinsNS1NS2ANS2BNS3NS4ANS4BNS5

Inhibition of viral protease activity (NS3/NS2B targeted); Inhibition of viral RNA-dependent RNA polymerase activity (NS5 targeted)[2][3][4]; Inhibition of viral methyltransferase/capping (NS5 targeted)[2]; Inhibition of membrane protein interactions (e.g., NS4B)[3]